It’s a new political era, and the pharmaceutical industry is beside itself with worry.

Via Science.org (emphasis added):

“Concerns about what a second Donald Trump (R) presidency could mean for public health and biomedical research ratcheted up this week after Robert F. Kennedy Jr. told supporters Trump has promised to give him “control” over agencies at the Department of Health and Human Services (HHS), including the Food and Drug Administration (FDA) and the National Institutes of Health (NIH)…

Public health researchers are alarmed, especially given Kennedy’s opposition to vaccines. “I can’t imagine anyone who would be more damaging to vaccines and the use of vaccines than RFK,” University of Minnesota epidemiologist Michael Osterholm told CNN…

Kennedy appears to be poised to wield substantial influence should Trump win. Trump has embraced Kennedy’s “Make America Healthy Again” agenda, which calls for removing allegedly harmful chemicals in foods and water and cracking down on ultraprocessed food, among other steps…